OTCM
CBDS
Market cap4mUSD
Jul 07, Last price
0.03USD
1D
5.76%
1Q
-18.71%
Jan 2017
-99.47%
IPO
-97.18%
Name
Cannabis Sativa Inc
Chart & Performance
Profile
Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; and holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013. Cannabis Sativa, Inc. is based in Mesquite, Nevada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 1,174 -24.69% | 1,559 -15.36% | |||||||
Cost of revenue | 1,263 | 2,712 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (89) | (1,153) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | (219) | ||||||||
Tax Rate | |||||||||
NOPAT | (89) | (934) | |||||||
Net income | (1,392) 45.66% | (956) -61.99% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 290 | 289 | |||||||
Long-term debt | 10 | 49 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | 778 | 418 | |||||||
Net debt | 151 | (139) | |||||||
Cash flow | |||||||||
Cash from operating activities | (63) | (236) | |||||||
CAPEX | (2) | ||||||||
Cash from investing activities | (10) | (57) | |||||||
Cash from financing activities | 60 | 196 | |||||||
FCF | 184 | (1,173) | |||||||
Balance | |||||||||
Cash | 150 | 477 | |||||||
Long term investments | |||||||||
Excess cash | 91 | 399 | |||||||
Stockholders' equity | (80,635) | (79,267) | |||||||
Invested Capital | 82,460 | 81,657 | |||||||
ROIC | |||||||||
ROCE | |||||||||
EV | |||||||||
Common stock shares outstanding | 54,554 | 38,068 | |||||||
Price | 0.01 -75.00% | 0.04 -79.78% | |||||||
Market cap | 491 -64.17% | 1,370 -73.71% | |||||||
EV | 2,002 | 2,522 | |||||||
EBITDA | 63 | (991) | |||||||
EV/EBITDA | 31.87 | ||||||||
Interest | 56 | 31 | |||||||
Interest/NOPBT |